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Recombination elevates the effective 
evolutionary rate and facilitates the 
establishment of HIV-1 infection in infants 
after mother-to-child transmission
Keri B. Sanborn1, Mohan Somasundaran1, Katherine Luzuriaga1 and Thomas Leitner2*
Abstract 
Background: Previous studies have demonstrated that single HIV-1 genotypes are commonly transmitted from 
mother to child, but such analyses primarily used single samples from mother and child. It is possible that in a single 
sample, obtained early after infection, only the most replication competent virus is detected even when other forms 
may have been transmitted. Such forms may have advantages later in infection, and may thus be detected in follow-
up samples. Because HIV-1 frequently recombines, phylogenetic analyses that ignore recombination may miss trans-
mission of multiple forms if they recombine after transmission. Moreover, recombination may facilitate adaptation, 
thus providing an advantage in establishing infection. The effect of recombination on viral evolution in HIV-1 infected 
children has not been well defined.
Results: We analyzed full-length env sequences after single genome amplification from the plasma of four subtype B 
HIV-1 infected women (11–67 env clones from 1 time point within a month prior to delivery) and their non-breastfed, 
intrapartum-infected children (3–6 longitudinal time points per child starting at the time of HIV-1 diagnosis). To 
address the potential beneficial or detrimental effects of recombination, we used a recently developed hierarchical 
recombination detection method based on the pairwise homoplasy index (PHI)-test. Recombination was observed in 
9–67 % of the maternal sequences and in 25–60 % of the child sequences. In the child, recombination only occurred 
between variants that had evolved after transmission; taking recombination into account, we identified transmission 
of only 1 or 2 phylogenetic lineages from mother to child. Effective HIV-1 evolutionary rates of HIV-1 were initially high 
in the child and slowed over time (after 1000 days). Recombination was associated with elevated evolutionary rates.
Conclusions: Our results confirm that 1–2 variants are typically transmitted from mothers to their newborns. They 
also demonstrate that early abundant recombination elevates the effective evolutionary rate, suggesting that recom-
bination increases the rate of adaptation in HIV-1 evolution.
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Background
Recombination contributes significantly to intrapatient 
HIV-1 diversity [1–3]. HIV-1 recombination is a complex 
phenomenon defined by both the template switching 
rate of the viral reverse transcriptase and the probability 
of coinfection of a single host cell [4, 5]. Estimates of the 
effective recombination rate based on longitudinal stud-
ies of patient samples range from 1.4  ±  0.6  ×  10−5 to 
1.38  ×  10−4 recombinations per site per generation [3, 
5], and over time recombinants may accumulate in as 
many as 1 out of 3 env sequences [6]. While widespread 
among many organisms, including eukaryotes, bacteria 
and viruses, the role of recombination is still debated 
[7–10]. Clearly, recombination can bring beneficial alleles 
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together, increasing the fitness of the recombinant, but 
recombination may also separate beneficial alleles that 
occur on the same genome. Theoretical studies have 
shown that the benefit of recombination depends on fac-
tors such as the interplay of recombination and substi-
tution rates, population size, and epistatic interactions 
[11–17]. However, the lack of direct evidence of whether 
recombination is beneficial or detrimental calls for addi-
tional studies, where rapidly evolving, recombining retro-
viruses may provide a good model system.
HIV-1 sequences observed within the first few months 
of mucosal transmission are typically homogeneous due 
to the transmission bottleneck [18–21], subsequently 
diverging and diversifying over the course of infection 
[22–24]. Studies have shown an inverse relationship 
between the rate of viral evolution and disease progres-
sion [25–30], including in vertically infected infants [26], 
likely due to immune selective pressures. Importantly, 
recent theoretical work suggested that recombination 
may accelerate HIV-1 adaptation [17]. While the role 
of recombination in the establishment of HIV-1 infec-
tion is unknown, evolutionary theory suggests [11–16] 
that recombination may alter the genetic variation upon 
which natural selection can operate. This would thus 
likely increase the overall evolutionary rate. Additionally, 
because simple phylogenetic analysis ignores recombina-
tion by assuming single parents of each lineage, frequent 
recombination of HIV-1 within an individual could also 
potentially mask the transmission of multiple variants. 
Thus, because recombination may be fundamentally 
important to HIV-1 infection and evolution, and because 
recombination may interfere with standard phylogenetic 
analyses, it is important to consider potential recom-
binants in the assessment of HIV-1 transmission.
Mother-to-child HIV-1 transmission (MTCT) is the 
primary mode of pediatric infection, accounting for up 
to 16  % of all HIV-1 transmission events globally [31]. 
While combination anti-retroviral (ARV) regimens can 
effectively reduce MTCT, the use of ARV is limited by 
cost and logistical requirements in limited-resource 
settings. Most studies evaluating MTCT specifically 
have been limited to one time point post-transmission. 
However, the possibility remains that additional vari-
ants are transmitted that do not execute the infection or 
post-transmission steps as efficiently as those detected 
early in infection. Although present at a low level early 
in infection, these variants could later expand and con-
tribute to the course of infection. Such variants may also 
recombine with more frequent variants, and therefore 
not be detected with simple phylogenetic methods. Thus, 
evaluating longitudinal samples is critical to determin-
ing whether additional variants may be transmitted but 
missed during early sampling.
In this study, we evaluated HIV-1 env sequences 
obtained from samples collected longitudinally from four 
mother–child pairs (1) to evaluate what effects recombi-
nation may have on HIV-1 transmission and the subse-
quent evolutionary rate, and (2) to determine the number 
of variants transmitted from mother to child. We found 
high proportions of recombinant HIV-1 forms in both 
the mothers and their infants and that recombination 
elevates the effective evolutionary rate. Taking recombi-
nation into account, we identified transmission of 1 or 2 
phylogenetic lineages from mother to child. Recombina-
tion only occurred between variants that evolved after 
transmission; recombinant forms thus did not hide mul-
tiple transmitted maternal HIV-1 variants. Our results 
show that recombination occurs frequently and appears 
to contribute significantly to the early diversification of 
the viral quasispecies in infants.
Results
Widespread recombination in mother and child HIV‑1 
populations
Initial phylogenetic analyses of the env sequences from 
the four mother–child pairs showed low statistical sup-
port for many clades, and dividing the long sequences 
into five fragments (~500 nt each) showed that the 
phylogeny across those fragments was not stable (data 
not shown). To assess whether this instability could be 
explained by recombination, we applied a recently devel-
oped hierarchical test based on the PHI-test [32, 33], 
henceforth referred to as h-PHI. Because apolipopro-
tein B mRNA editing enzyme, catalytic polypeptide-like 
(APOBEC)-induced hypermutation [34, 35] may cause 
homoplasies that may mislead recombination detec-
tion, we first removed hypermutants from the data; three 
hypermutant sequences were detected and removed in 
child P1024 (P1024-1B, P1024-7A, P1024-2B). The h-PHI 
test showed that both the mother and the child HIV-1 
populations carried many recombinants (Table  1). The 
h-PHI test iteratively removed recombinant taxa until the 
remaining set of mother and child sequences indicated 
at Pr(PHI) >0.05 that no recombination signal remained 
(Fig.  1). In the mother–child pairs M1001/P1024 and 
M1002/P1031, about half of all of the sequences detected 
were recombinants according to h-PHI (Table 1). M1003/
P1189 and M1007/P1046 had fewer recombinants 
detected; this can be explained by an overall lower 
diversity, which should make detection less powerful. 
Note that when the ancestral sequences of the recom-
binant are genetically similar, there should be less of a 
biological impact of recombination, and thus the detec-
tion ability should to some degree follow the general 
genetic diversity in the recombining population (the frac-
tion of h-PHI-detected recombinants compared to the 
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population diversity in all eight patients showed a Pear-
son’s product-moment correlation of 0.622, p = 0.099).
Removing hypermutant and recombinant sequences 
from the populations resulted in phylogenies with more 
stability. Figure 2 shows the result for pair M1001/P1024 
(data from all pairs are shown in Additional file  1: Fig-
ure S1). A SplitsTree analysis clearly shows the many 
alternative relationships between the taxa caused by the 
multiple ancestries of the recombinant taxa. When the 
recombinants detected by our h-PHI test were removed 
(as were hypermutants), enough stability was achieved 
in the remaining phylogeny to assess how many separate 
phylogenetic lineages must have established the child 
population (Additional file 1: Figure S1). Based on non-
recombinant taxa only, P1024 was infected by two sepa-
rate lineages from M1001, and the other children (P1031, 
P1189, P1046) were all infected by a single maternal 
HIV-1 lineage.
Recombination does not hide multiple transmitted taxa
While the results from the non-recombinant taxa sug-
gested 1 or 2 transmitted maternal HIV-1 lineages, it 
remained possible that several maternal lineages were 
transmitted, which subsequently recombined in the child 
and died out before sampling (or only existed at lev-
els below the detection limit of our sequencing system), 
leaving only the trace of multiple transmitted forms in 
the recombinant taxa. To evaluate this possibility, we 
tested whether any of the h-PHI-identified recombinants 
were chimeric between >1 maternal ancestors, or if 
recombination only involved ancestral taxa from within 
the child’s own HIV-1 population using “Recombination 
Identification Program” (RIP) analysis, which calculates 
the similarity of a recombinant sequence to potential 
ancestral sequences in a sliding window analysis. Figure 3 
shows examples of the RIP analyses of P1024 h-PHI iden-
tified recombinant taxa. Three different types of patterns 
were typically observed: (1) no significant similarity to 
any potential available ancestral sequences; (2) partial 
significant similarity to 1 available ancestor; and (3) par-
tial significant similarity to >1 available ancestor. The 
instances in which RIP could not find significant simi-
larity, partially or fully, are explained by two factors: (1) 
lack of non-recombinant ancestor, i.e., the ancestor was 
not detected in our set of sequences (not available to our 
analysis), and (2) all ancestors were so similar that no sin-
gle sequence was significantly more similar to the recom-
binant than the others. These three patterns occurred in 
each of the children’s HIV populations (Additional file 2: 
Table S1). Importantly, neither in P1024, nor in P1031, 
P1189 or P1046, did we detect a significant trace of mul-
tiple maternal ancestor sequences using RIP, and thus 
these recombinants did not hide additional transmitted 
Table 1 Recombination detection results of the h-PHI test
Nseq number of sequences investigated, Nhyper number of hypermutants detected, Pr(PHIall) probability of PHI-test with all non-hypermutant sequences, Pr(PHIend) 
probability of PHI-test with recombinant sequences removed at the end of the h-PHI iterations, Nrecomb number of recombinant found with the h-PHI algorithm, 
Diversity mean pairwise distance among all non-hypermutated taxa measured in 10−3 substitutions/site using a F84 substitution model, Recomb (%) percent 
recombinants found out of all sequences
MTCT pair Nseq Nhyper Pr(PHIall) Pr(PHIend) Nrecomb Diversity Recomb (%)
M1001/P1024 18/38 0/3 2.23e−24 0.269 12/23 15/25 67/60
M1002/P1031 25/56 0/0 1.21e−16 0.053 15/26 13/23 60/46
M1003/P1189 11/31 0/0 1.93e−10 0.321 1/12 5/26 9/39
M1007/P1046 22/67 0/0 1.17e−3 0.079 2/17 5/14 9/25
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Fig. 1 Progress of h-PHI removing recombinant taxa among mother–
child sequences. The h-PHI test removed the sequence contributing 
most to the PHI signal in each iteration, recalculating the overall PHI 
score after each removal as the homoplasy relationships changed 
depending on the current sample. Datasets with many recombinants 
started at a lower Pr(PHI) value and had more taxa removed (Table 1). 
The colored lines show the iterative progress, and the dashed line 
indicates Pr(PHI) = 0.05, above which the iterative removal process 
stopped
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forms beyond those detected among the non-recom-
binant taxa. In fact, all recombination among the child 
HIV-1 populations occurred in the child between line-
ages that had formed after transmission.
In summary, P1024 was infected by two maternal 
HIV-1 variants, while P1031, P1189 and P1046 were 
infected by 1 variant each from their respective mothers. 
While there was widespread recombination in all moth-
ers and children, all recombination in the child HIV-1 
populations occurred among lineages that had split off 
the transmitting form after transmission.
Recombination boosts the HIV‑1 effective evolutionary 
rate
As the HIV-1 population becomes established, the cor-
responding phylogeny grows in height as the phyloge-
netic lineages accumulate mutations. In reference to the 
mother’s HIV-1 population, the evolutionary rate in the 
child’s population generally slows down towards the tips 
of the tree (Table 2). All child HIV-1 populations evolved 
more slowly at the full tree height than closer to the root 
when the population was initiated (p  =  0.008, paired 
Wilcoxon signed rank test). P1024 had a much higher 
apparent evolutionary rate than the other child popula-
tions, which may be explained by the fact that P1024 was 
infected with 2 HIV-1 variants from the mother’s popula-
tion, which amplifies the apparent evolutionary rate due 
to the transmitted ancestral divergence [36, 37]. In P1189 
and P1046, the evolutionary rates first increased as the 
trees grew (indicated by the range in Table  2) and then 
decreased to levels below any initial rate, hence following 
the general pattern in these HIV-1 populations. Impor-
tantly, recombination boosted the evolutionary rates 
across the tree height (Table 2).
To investigate the evolutionary rate as a function of 
time, we divided the sampled time period on the mid-
dle sample (potential inflection point) and compared the 
resulting rates on each side (rates 1 and 2 in Table 3). Sim-
ilar to the tree height, the evolutionary rate as a function 
of time also decreased after a high initial level (p = 0.016, 
paired Wilcoxon signed rank test). P1024 again showed 
much higher rates, again explained by transmission of 
>1 maternal variant. Notably, while recombination again 
inflated the evolutionary rates (p  =  0.016, paired Wil-
coxon signed rank test), the effect appeared to be less on 
the time scale than on the tree height level. With viral 
load data from only two of the transmission pairs, we 
could not observe any correlation between the dynamics 
of the evolutionary rate and viral load or antiviral treat-
ment. There was also no clear pattern in our data that 
P1024-E1
M1001-F1
M1001-M10
M1001-R4
M1001-T1
M1001-G1
P1024-M1
P1024-H2
M1001-J7
P1024-19B
P1024-9B
P1024-4A
P1024-23B
P1024-17C
P1024-11B
P1024-2C
P1024-1E
P1024-10A
*
*
*
*
*
*
0.01
a b
P1024-M1
M1001-
G1
M1
00
1-T
1
M1
00
1-R
4M
10
01
-M
10
M
10
01
-F
1
M
1001-J7
P1024-H
2P1024-E1
P1024-19B
P1024-9BP1024-4A
P1024-23B
P1024-17C
P1024-2C
P1
02
4-1
1B
P1024-1E
P1024-10A
M1001 recombinant
P1024 hypermutant
P1024 recombinant
TF-1
TF-2
Non-recombinant
maternal population
Fig. 2 Removing recombinant taxa stabilized the reconstructed phylogeny of mother–child transmission. SplitsTree inference of mother–child pair 
M1001/P1024 (a) and the corresponding dichotomous phylogeny of the non-recombinant taxa after removal of the h-PHI-detected recombinant 
taxa (b). Maternal non-recombinant taxa are labeled with bold text names, and child non-recombinant taxa are labeled with plain text names. 
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suggested that recombination was more common in ear-
lier or later samples from the child.
Overall, these results suggest that the initial evolution 
was rapid in order to quickly adapt to the new (child) 
host. As new mutations were established, the evolution 
gradually slowed down. This qualitative pattern was inde-
pendent of whether recombinants were included or not, 
but importantly, recombination quantitatively elevated 
the evolutionary rates.
Env sequence characteristics in mother–child pairs
Previous studies have demonstrated universally conver-
gent features in transmitted variants compared to the 
sequences predominating in the transmitter, suggest-
ing that these features may somehow offer an advantage 
during HIV-1 transmission. In addition to CCR5 (R5)-
tropism, fewer N-linked glycosylation sites, and lower V3 
region charge, additional motifs have been reported in the 
literature that have various functional effects, including 
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Fig. 3 Typical examples of RIP analyses of h-PHI-identified recombinant taxa. These examples come from M1001/P1024 and are representative of all 
RIP results among all four mother–child pairs investigated in this study (Additional file 2: Table S1). Panel a shows a result where the query sequence 
(h-PHI-identified recombinant taxon P1024-7C) does not have a significant similarity with any one detected non-recombinant maternal or child 
sequence in any part of the sequenced genome (2500 nt of env). Panel b shows an example where the h-PHI-identified recombinant taxon P1024-
15D has one parent (P1024-17C) significantly more similar in part of the sequence (approximately nucleotide sites k = 700–2500) and likely one 
missing parent (sites 1–700) in the detected set of non-recombinant potential parents. Panels c and d show examples of results where >1 parent 
shows significant similarity to some part of the query sequence (P1024-3A to P1024-2C and P1024-11B, and P1024-10A to P1024-2C and P1024-
19B). These latter two panels also show the situation where no parent is significantly more similar than the other potential parents because several 
are fairly similar (sites 1500–2500). The similarity, s(k), to each non-recombinant potential parent is displayed as a colored line, identified in the list to 
the right of the RIP result panels. Each RIP result also shows the best match in the corresponding color as the lower horizontal bar in the top of each 
panel, and if the match is significant, another colored bar on top of that is shown for the corresponding sites
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increased Env density on virions, resistance to broadly 
neutralizing antibodies, increased coreceptor binding, 
and escape of cytotoxic T lymphocyte (CTL) recognition 
[19, 38–42]. To evaluate whether recombination brought 
together or separated such known sequence motifs, indi-
cating a fitness advantage or disadvantage, respectively, 
we evaluated the computationally predicted co-receptor 
tropism, V-region length and charge, and number of 
potential N-linked glycosylation (PNG) sites, as well as 
the presence of potentially advantageous motifs, in the 
sequences obtained from the four mother–child pairs. In 
silico analysis of the Env sequences from our cohort indi-
cated that all transmitted Envs were indeed R5-tropic, 
although one CXCR4 (X4)-tropic Env sequence was pre-
dicted in one of the children at a later time point (P1046, 
at 168.62  months, Additional file  3: Table S2). In order 
to simplify the analysis of sequence motifs, and to con-
sider potentially disadvantageous motifs, e.g., PNGs 
that allow for stronger antibody binding, we analyzed 
the lack of such PNGs, as Envs lacking these motifs 
may have an advantage during selection. Counting the 
potentially advantageous form of each motif enabled us 
to sum together the number of such motifs in order to 
compare recombinant and non-recombinant sequences. 
The number of potentially advantageous motifs present 
in the Env sequences varied between the mother/child 
pairs. Recombinant sequences contained approximately 
the same numbers of these motifs as non-recombinant 
sequences, indicating that recombination did not result 
in the net accumulation or loss of the potentially advan-
tageous motifs considered (Additional file  3: Table S2). 
The distribution of most motifs was similar between the 
maternal Env sequences and those in the child at the first 
time point, suggesting that these motifs were not pref-
erentially transmitted from mother to child (Additional 
file 4: Table S3). It is possible that there are other, yet uni-
dentified or outside env, motifs/alleles that may consti-
tute fitness advantages during early HIV infection.
Discussion
Analysis of full-length env sequences from HIV-1 
infected women and their infants over multiple time 
points revealed extensive recombination. Moreover, the 
observed recombination was associated with an elevated 
effective evolutionary rate, suggesting that recombination 
of HIV-1 facilitates adaptation to the new host after trans-
mission. It has been previously shown that recombination 
may lead to the rapid emergence of antiviral drug resist-
ance [43–45]. Together, these results support the notion 
that recombination is advantageous for HIV-1 adaptation.
Taking recombination into account, the examination of 
longitudinal samples confirmed the transmission of just 
one variant in all but one infant. These results are con-
sistent with the results of our previous work with this 
cohort [38], which demonstrated the transmission of one 
or two variants from mother to child in each pair.
Recombination is known to occur during HIV-1 rep-
lication [46, 47] and inter-subtype recombinants are 
both frequent and successful in the worldwide HIV-1 
epidemic [48–50]. Since genetic variability is typi-
cally much smaller at the level of the individual host, 
intra-host (and intra-subtype) recombinants have been 
described but are more difficult to detect [4–6, 51]. 
While recombination can create additional genetic 
diversity upon which natural selection can rapidly select 
advantageous variants and purge deleterious mutations 
from a population [11–15], recombination may have 
costs and may impede adaptation due to multidimen-
sional epistasis, e.g., when new alleles are beneficial 
only if they accumulate in a prescribed order [16]. Thus, 
theoretically, recombination can either bring beneficial 
alleles together or separate beneficial alleles that already 
occur on the same genome. The debate on why sexual 
reproduction exists has led some authors to question 
why RNA viruses recombine [10]. Addressing these 
theoretical issues, it was recently shown that recom-
bination substantially increases the rate of adaptation 
Table 3 Evolutionary rates across sampling times
Rate 1 rate before potential inflection point, Rate 2 rate after potential inflection 
point, Infection time time of potential change in rate. All rates are in units of 10−5 
substitutions site−1 day−1 and were found at R2 > 0.90 and p < 0.001 by ordinary 
least squares regression, except Rate 2 of P1024 with recombinants at R2 = 0.82
Patient With recombinants Inflection time 
(days)
Without recom‑
binants
Rate 1 Rate 2 Rate 1 Rate 2
P1024 15.4 9.44 1163 4.38 1.88
P1031 3.95 1.84 1377 3.16 1.91
P1189 3.02 3.30 886 2.17 1.79
P1046 4.33 0.67 706 3.58 0.56
Table 2 Evolutionary rates across tree height
Initial rate rate at start of child HIV-1 subtree, Final rate rate at tips of child HIV-1 
subtree. All rates are in units of 10−5 substitutions site−1 day−1 and were found 
at R2 > 0.90 and p < 0.001 by ordinary least squares regression
Patient With recombinants Without recombinants
Initial rate Final rate Initial rate Final rate
P1024 55.4 8.40 19.8 3.08
P1031 3.90 1.60 3.46 2.73
P1189 1.90–3.74 1.38 5.19 1.28
P1046 2.81–6.80 0.56 2.62–4.72 0.63
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among a wide range of population sizes and mutation 
rates [17]. Our results indicating that recombination 
elevated the evolutionary rate are supportive of the ben-
eficial effect of recombination during the establishment 
of HIV-1 infection in a new host.
If recombinants have a fitness advantage, one would 
expect them to carry more advantageous alleles/motifs 
as a result of recombination joining them onto the same 
genome. In our analyses, recombinants did not contain 
higher proportions of computationally inferred sequence 
features such as co-receptor tropism, V-region length 
and charge, number of PNG sites, or other motifs that 
have been previously described in the literature as poten-
tially advantageous in transmission or early infection. It 
seems likely that these are not the features that additively 
make genomes more fit during the early stages of infec-
tion. Rather, escaping additional cytotoxic T lymphocyte 
and antibody immune epitopes not captured by these 
features may drive the early selection of recombinants.
After the early increase in effective evolutionary rates, 
the children’s viruses displayed a decreasing HIV-1 evo-
lutionary rate as both the tree height and time grew. This 
has also previously been described in HIV-1 infected 
adults [23]. The decreasing evolutionary rate may be 
explained by the fact that functional constrains may 
make it harder to find advantageous mutations once the 
initial mutations have been established in the new host 
[23]; decreasing pressure from the immune system asso-
ciated with disease progression [23] and the introgression 
of HIV-1 from latent reservoirs [32] may also contribute.
The detection of high levels of recombination in mater-
nal HIV-1 sequences suggests that recombination is not 
limited to the establishment of infection. As HIV-1 is 
relentlessly confronted by the adaptive immune system, 
HIV-1 accumulates mutations to evade recognition, lead-
ing to an inverse relationship between the rate of viral 
evolution and disease progression [25–30]. Thus, it is 
likely advantageous for HIV-1 to recombine throughout 
the entire infection period.
Conclusions
Longitudinal data provide the advantage that many bio-
logical processes can be directly observed, rather than 
predicted by modeling from cross-sectional data. Here, 
we show that recombination is common and increased 
the effective evolutionary rate but did not obscure the 
transmission of multiple HIV-1 variants from mothers 
to their children. As in adults, the overall evolutionary 
rate decreased as HIV-1 infection matured in the chil-
dren. Altogether, these data suggest a beneficial effect of 
recombination during the establishment of HIV-1 infec-
tion in a new host.
Methods
Patient materials
We studied four HIV-1 subtype B infected mothers and 
their infected infants (Table  1), who contracted HIV-1 
at birth, based on standard diagnostic criteria [52]. Env 
sequences were isolated from the mothers and children 
using single-genome amplification (SGA) from plasma 
samples. Maternal samples for these analyses were 
obtained at or within a month of delivery, and infant 
samples were obtained from the time point of diagnosis 
as well as from several time points thereafter. The chil-
dren were not breastfed, and thus the sequences obtained 
at later time points represent variation originating from 
the variant(s) existing in the mother before or at birth.
Ethics statement
All studies involving human samples were approved by 
the University of Massachusetts Medical School Institu-
tional Review Board for Human Subjects. Informed, writ-
ten consent was obtained from each of the women for 
their own and their infants’ participation prior to enroll-
ment in this study.
PCR amplification and DNA sequencing of HIV‑1 env
Full-length HIV-1 env was amplified from RNA isolated 
directly from plasma by endpoint dilution nested reverse 
transcription polymerase chain reaction (RT-PCR), as 
previously described [38]. The outer and inner primer 
pairs, flanking the N- and C-termini of the env sequence 
(HXB2 positions 5948-8916) were the same as reported 
by Wei et al. [53]. The ~3 kb env amplicons were gel puri-
fied using the QIAquick Gel Extraction kit (QIAgen, 
Valencia, CA, USA) and sub-cloned into the pcDNA3.1/
V5-His TOPO TA vector (Invitrogen Life Technologies, 
Carlsbad, CA, USA), then used to transform OneShot 
Stbl3 chemically competent E. coli (Invitrogen) following 
the manufacturer’s instructions. Colonies containing full-
length inserts in the correct orientation were identified 
and screened for functionality using a syncytia assay, as 
previously described [38]. Each functional clone obtained 
from each subject arose from an independent endpoint 
dilution PCR.
The full-length gp160 of all viable molecular env clones 
were sequenced using BigDye Terminator chemistry. 
Sequences were assembled and trimmed using Geneious 
version R6 (Biomatters Ltd., Auckland, New Zealand). 
The sequences are available from GenBank under nucleo-
tide sequence accession numbers KT283686–KT283953.
Env sequence characteristics analyses
Env sequences from each subject were aligned using 
Geneious. The V region length, charge, and number of 
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potential N-linked glycosylation sites (PNGs) were deter-
mined using the Variable Region Characteristics calcu-
lator on the Los Alamos National Laboratory website 
(http://www.hiv.lanl.gov/content/sequence/VAR_REG_
CHAR/) using HXB2 as a reference sequence. Corecep-
tor tropism (CCR5 vs. CXCR4) was predicted in silico 
using the WebPSSM tool (http://indra.mullins.microbiol.
washington.edu/webpssm/).
Phylogenetic analyses
For our phylogenetic analyses, all MTCT pairs were 
aligned separately using MAFFT under the FFT-NS-i 
algorithm [54], and the alignments were codon corrected 
using GeneCutter [55] and manually checked using SeaV-
iew [56].
Hypermutants, i.e., dead-end HIV-1 variants with 
excessive A-to-G mutations induced by the host APOBEC 
mechanism [34, 35], were identified and removed using 
Hypermut (http://www.hiv.lanl.gov/content/sequence/
HYPERMUT/hypermut.html) with the default APOBEC 
pattern G- >A[RD] over G- >A[YN|RC].
Recombinant sequences were identified by a hierarchi-
cal test, h-PHI, as previously described [32], which finds 
all recombinants in a set of sequences (MTCT pair) until 
the pairwise homoplasy index (PHI) test [33] indicates 
a probability Pr(PHI) ≥0.05 that homoplasies may have 
accumulated by other processes than recombination. All 
such identified recombinant sequences were then evalu-
ated using RIP [57] with a window size of 400 nt, con-
fidence threshold  =  0.9, and alignment gaps stripped 
(very few were present in the data). Potential ances-
tral sequences were (1) all non-recombinant sequences 
remaining after h-PHI identification in each MTCT pair, 
and (2) all sequences except the query sequence in each 
MTCT pair. The results from using “all” sequences as 
references were consistent with only using non-recom-
binant references, but with less power to find significant 
ancestral assignments because a recombinant ancestor 
also had its non-recombinant ancestor in the reference 
set, which would compete in the statistical assignment. 
Because RIP can only use up to 26 reference sequences, 
we removed reference sequences based on phylogenetic 
closeness progressively until n = 26, and also used only 
the maternal or child references in separate RIP analyses.
Phylogenetic trees were inferred using PhyML [58] 
under a GTR + I + G substitution model, four category 
Gamma optimization, with a Bio-NJ starting tree and 
best of NNI and SPR search, and aLRT SH-like branch 
support. Phylogenetic networks were inferred using 
SplitsTree [59] under the default settings.
Molecular clock analyses were performed by ordinary 
least squares regression of tree-based divergence over 
time, piece-wise with a potential inflection point at the 
middle time point for time-dependent evolutionary rate 
analyses. The rates on each side of the potential inflec-
tion point are based on enough time to estimate reliable 
rates, as HIV-1 populations have been shown to evolve 
significantly in about 1  month [24]. For analyses of the 
evolutionary rate as a function of the tree height, the evo-
lutionary rate was estimated in a sliding window moving 
from the tree root to tips as previously described [23]. 
The window size was adjusted for each tree so that each 
window would contain some tips and was moved at 1/10 
of the window size in each analysis step.
h-PHI and molecular clock analyses were automated 
using R [60].
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